Ariad Pharmaceuticals

Listing Websites about Ariad Pharmaceuticals

Filter Type:

ARIAD Pharmaceuticals - Wikipedia

(1 days ago) ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer … See more

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


ARIAD Pharmaceuticals, Inc. LinkedIn

(9 days ago) WebARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is now part of Takeda Pharmaceuticals. Website http://www.takeda.com Industries Pharmaceutical Manufacturing …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Takeda Completes Acquisition of ARIAD Pharmaceuticals, …

(8 days ago) WebTakeda Pharmaceutical Company Limited (“Takeda”) today announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ARIAD PHARMACEUTICALS, INC. : Stock Price

(3 days ago) WebARIAD PHARMACEUTICALS, INC. : Stock Price US04033A1007 MarketScreener Homepage Equities United States Nasdaq Ariad Pharmaceuticals, Inc. Summary …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Harvey Berger - Wikipedia

(3 days ago) OverviewEarly life and educationCareerAwardsPersonal life and philanthropyHarvey J. Berger, M.D. is an American physician-scientist, entrepreneur and biotechnology executive. He was the founder and chairman and chief executive officer of ARIAD Pharmaceuticals, Inc. for 25 years, starting in 1991 and became advisor to the board in 2016. He was also executive chairman at Medinol, Inc from 2017 to 2018. In February 2018, Berger was appointed to the Dana–Farber Cancer Institute Board of Trustees.

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


ARIA Ariad Pharmaceuticals Inc. - Stocktwits

(4 days ago) WebARIA Ariad Pharmaceuticals Inc. 6,421 Market Cap $0.00 Volume (M) 7.22M 52-Wk High $0.00 52-Wk Low $0.00 About Feed Fundamentals News There is no chart data …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Home - Aria Pharmaceuticals

(2 days ago) WebAria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel, small molecule therapies for patients in need of new treatments across many complicated diseases. These …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ARIA ARIAD Pharmaceuticals, Inc. - Seeking Alpha

(6 days ago) WebStock Screener ETF Screener Comparisons Subscribe to Premium ARIA ARIAD Pharmaceuticals, Inc. Stock Price & Overview ARIA is defunct since May 9, 2018.

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ariad Pharmaceuticals (ARIA) Stock Forecast, Price & News

(6 days ago) WebARIAD Pharmaceuticals, Inc. (ARIAD) is an oncology company. The Company is focused on transforming the lives of cancer patients with medicines. The Company's product pipeline includes Iclusig …

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs


Takeda to Acquire ARIAD Pharmaceuticals, Inc.

(4 days ago) WebARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts is focused on discovering, developing and commercializing precision therapies for patients with rare …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ARIAD Pharmaceuticals - Crunchbase Company Profile & Funding

(1 days ago) WebARIAD is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. Acquired by Takeda Cambridge, …

Url: Visit Now

Category:  Cancer Detail Drugs


FDA approves brigatinib for ALK-positive metastatic NSCLC

(6 days ago) WebOn May 22, 2020, the Food and Drug Administration approved brigatinib (ALUNBRIG, ARIAD Pharmaceuticals Inc.) for adult patients with anaplastic lymphoma kinase (ALK) …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Takeda to Acquire Ariad Pharmaceuticals for $5.2B

(1 days ago) WebAriad Pharmaceuticals has agreed to be acquired by Takeda Pharmaceutical for approximately $5.2 billion, the companies said today, in a deal …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ARIA - Ariad Pharm Stock Price - Barchart.com

(3 days ago) WebAriad Pharm Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Ariad Pharmaceuticals is engaged in the …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Merck and ARIAD Pharmaceuticals Provide Update on FDA …

(8 days ago) WebAbout ARIAD ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Ariad Pharmaceuticals Archives - GEN - Genetic Engineering and

(9 days ago) WebTakeda Pharmaceutical has absorbed only part of the nearly 300-employee workforce it inherited when it acquired Ariad Pharmaceuticals earlier this year, though exactly how

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


Core Pharma About Us

(6 days ago) WebAs of January 2018, CorePharma was acquired by a group of industry investors with an unwavering commitment to remain a trusted, reliable and preferred partner of choice for …

Url: Visit Now

Category:  Drug Detail Drugs


Operations - Sunrise Pharmaceutical, Inc.

(7 days ago) WebSunrise Pharma is committed to providing products and services that meet or exceed all quality requirements and applicable standards and specifications. Each employee is …

Url: Visit Now

Category:  Drug Detail Drugs


Contact - Xiromed

(2 days ago) WebIf you are experiencing a medical emergency, please contact your health care provider. To speak with a medical information professional about your medical question, to report an …

Url: Visit Now

Category:  Health Detail Drugs


PDL BioPharma Completes Royalty Transaction with ARIAD …

(6 days ago) WebARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on …

Url: Visit Now

Category:  Pharmaceutical Detail Drugs


ARIAD Pharmaceuticals Company Profile - Craft

(8 days ago) WebARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. It is working on …

Url: Visit Now

Category:  Pharmaceutical,  Cancer Detail Drugs